Science Explorer Back to mapMap
Discussion
Researcher · Hermanos Ameijeiras Hospital · Cuba

Elia Nenínger Vinageras

Elia Nenínger Vinageras publishes mostly in Pulmonary and Respiratory Medicine, Oncology and Epidemiology, on topics such as Lung Cancer Treatments and Mutations, Lung Cancer Research Studies and Lung Cancer Diagnosis and Treatment.

OpenAlex
World rank
#5,156,929
of 7,710,434 ranked researchers
Rank in Cuba
#993
of 7,334
Works
29
Citations
523
Citations per work
18.0
h-index
6
i10-index 6Top 78% in Pulmonary and Respiratory Medicine
Elia Nenínger Vinageras

What does Elia Nenínger Vinageras research?

Elia Nenínger Vinageras's work is mostly in Medicine (60%), Health Professions (7%).

Health Sciences: 19 works · 67.0% of their workMedicine: 17 works · 60.2% of their workOncology: 6 works · 21.9% of their workPulmonary and Respiratory Medicine: 6 works · 21.9% of their workEpidemiology: 2 works · 6.8% of their workPhysiology: 2 works · 5.5% of their workPublic Health, Environmental and Occupational Health: 1 works · 4.1% of their workHealth Professions: 2 works · 6.8% of their workGeneral Health Professions: 2 works · 6.8% of their workEverything else: 10 works · 33.0% of their workTHEIR WORKElia NeníngerVinageras29works
Health Sciences67%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine1760.2%
    2. Health Professions26.8%
  2. Everything else1033.0%
  1. 1Pulmonary and Respiratory Medicine22% of their works
  2. 2Oncology22% of their works
  3. 3Epidemiology7% of their works
  4. 4General Health Professions7% of their works
  5. 5Physiology6% of their works
  6. 6Public Health, Environmental and Occupational Health4% of their works

Research topics

Which keywords describe Elia Nenínger Vinageras's research?

The keywords of their largest research topics: Clinical Trials, Targeted Therapy, Chemotherapy, ALK Inhibitors, EGFR Mutations, Health Promotion, CT Screening and Genomic Profiles.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 20 words, with their numbers
  1. Clinical Trials122 topics
  2. Targeted Therapy122 topics
  3. Chemotherapy102 topics
  4. ALK Inhibitors71 topic
  5. EGFR Mutations71 topic
  6. Health Promotion62 topics
  7. CT Screening51 topic
  8. Genomic Profiles51 topic
  9. Lung Cancer51 topic
  10. Small-Cell Lung Cancer51 topic
  11. Healthcare Systems41 topic
  12. Public Health41 topic
  13. Dendritic Cells31 topic
  14. Immune Checkpoint Blockade31 topic
  15. Immunity31 topic
  16. PD-1 and PD-L131 topic
  17. Family Caregivers21 topic
  18. Neuroendocrine Tumors21 topic
  19. Pancreatic Neuroendocrine Tumors21 topic
  20. Self-Care21 topic

Where does Elia Nenínger Vinageras work?

Elia Nenínger Vinageras's main affiliation in the publication record is Hermanos Ameijeiras Hospital, Cuba.

How many publications and citations does Elia Nenínger Vinageras have?

OpenAlex counts 29 works and 523 citations for Elia Nenínger Vinageras, an h-index of 6, ranking #5,156,929 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Elia Nenínger Vinageras. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.